BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32926122)

  • 1. Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.
    Phillips L; Pavisic J; Kaur D; Dorrello NV; Broglie L; Hijiya N
    Blood Adv; 2020 Sep; 4(18):4358-4361. PubMed ID: 32926122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound findings in patients with COVID-19 pneumonia in early and late stages: Two case-reports.
    Zieleskiewicz L; Duclos G; Dransart-Rayé O; Nowobilski N; Bouhemad B
    Anaesth Crit Care Pain Med; 2020 Jun; 39(3):391-392. PubMed ID: 32417024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute respiratory distress syndrome secondary to SARS-CoV-2 infection in an infant].
    Lahfaoui M; Azizi M; Elbakkaoui M; El Amrani R; Kamaoui I; Benhaddou H
    Rev Mal Respir; 2020 Jun; 37(6):502-504. PubMed ID: 32471720
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19-related Acute Respiratory Distress Syndrome.
    van der Zee P; Somhorst P; Endeman H; Gommers D
    Am J Respir Crit Care Med; 2020 Jul; 202(2):280-284. PubMed ID: 32479112
    [No Abstract]   [Full Text] [Related]  

  • 5. Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management.
    Bos LDJ; Paulus F; Vlaar APJ; Beenen LFM; Schultz MJ
    Ann Am Thorac Soc; 2020 Sep; 17(9):1161-1163. PubMed ID: 32396457
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum.
    Ronco C; Reis T; De Rosa S
    Blood Purif; 2020; 49(3):255-258. PubMed ID: 32172242
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19: A Call for Action, Collaboration, Reason, and Unity.
    Gaisa M
    Eur Urol Focus; 2020 Sep; 6(5):1026-1027. PubMed ID: 32513520
    [No Abstract]   [Full Text] [Related]  

  • 8. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
    Caocci G; La Nasa G
    Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrasound findings in patients with COVID-19 pneumonia in early and late stages: Two case-reports.
    Zieleskiewicz L; Duclos G; Dransart-Rayé O; Nowobilski N; Bouhemad B
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):571-573. PubMed ID: 32654908
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.
    Bos LDJ
    Am J Respir Crit Care Med; 2020 Aug; 202(4):622-624. PubMed ID: 32579026
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of respiratory failure due to covid-19.
    Wilcox SR
    BMJ; 2020 May; 369():m1786. PubMed ID: 32366375
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of COVID-19 Respiratory Distress.
    Marini JJ; Gattinoni L
    JAMA; 2020 Jun; 323(22):2329-2330. PubMed ID: 32329799
    [No Abstract]   [Full Text] [Related]  

  • 13. High-flow oxygen therapy with spontaneous breathing prono position in SARS-CoV-2 pneumonia.
    González-Castro A; Escudero-Acha P; Arnaiz F; Ferrer D
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Nov; 67(9):529-530. PubMed ID: 32709450
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms.
    Desnos C; Boussouar S; Hekimian G; Redheuil A; Combes A
    Crit Care; 2020 Nov; 24(1):638. PubMed ID: 33158462
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature.
    D'Abramo A; Lepore L; Palazzolo C; Barreca F; Liuzzi G; Lalle E; Nicastri E
    Int J Infect Dis; 2020 Aug; 97():236-239. PubMed ID: 32565366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 and rhinovirus/enterovirus co-infection in a critically ill young adult patient in Colombia.
    Orozco-Hernández JP; Montoya-Martínez JJ; Pacheco-Gallego MC; Céspedes-Roncancio M; Porras-Hurtado GL
    Biomedica; 2020 Oct; 40(Supl. 2):34-43. PubMed ID: 33152186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical feedback from experience with COVID-19: Specific considerations for extracorporeal membrane oxygenation.
    Fiore A; de Roux Q; Daami N; Clariot S; Folliguet T; Taccone FS; Mongardon N
    J Infect; 2020 Sep; 81(3):e59-e60. PubMed ID: 32579990
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
    Moore HB; Barrett CD; Moore EE; McIntyre RC; Moore PK; Talmor DS; Moore FA; Yaffe MB
    J Trauma Acute Care Surg; 2020 Jun; 88(6):713-714. PubMed ID: 32281766
    [No Abstract]   [Full Text] [Related]  

  • 19. Critical illness-associated cerebral microbleeds in COVID-19 acute respiratory distress syndrome.
    Cannac O; Martinez-Almoyna L; Hraiech S
    Neurology; 2020 Sep; 95(11):498-499. PubMed ID: 32727834
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2.
    Pagano A; Porta G; Bosso G; Allegorico E; Serra C; Dello Vicario F; Minerva V; Russo T; Altruda C; Arbo P; Mercurio V; Numis FG
    Respir Physiol Neurobiol; 2020 Sep; 280():103489. PubMed ID: 32629100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.